Dec 3 (Reuters) - Sierra Oncology Inc SRRA.O :
* SIERRA ONCOLOGY REPORTS ROBUST TRANSFUSION INDEPENDENCE RATES IN TRANSFUSION DEPENDENT MYELOFIBROSIS PATIENTS TREATED WITH MOMELOTINIB
Dec 3 (Reuters) - Sierra Oncology Inc SRRA.O :
* SIERRA ONCOLOGY REPORTS ROBUST TRANSFUSION INDEPENDENCE RATES IN TRANSFUSION DEPENDENT MYELOFIBROSIS PATIENTS TREATED WITH MOMELOTINIB